Mirabella Financial Services LLP Otonomy, Inc. Transaction History

Mirabella Financial Services LLP

  • $1.15 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$2.49 - $6.23 $59,137 - $147,962
-23,750 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$3.48 - $6.47 $31,452 - $58,475
-9,038 Reduced 27.56%
23,750 $154,000
Q3 2020

Nov 13, 2020
BUY
$3.16 - $4.36 $103,610 - $142,955
32,788 New
32,788 $133,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email